Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients

Amyloid

Volumn 19, Issue 3, 2012, Pages 146-151

  Beirão, Nuno M ^a   Matos, Maria E ^b   Meneres, Maria J ^a   Beirão, Idalina M ^a,b   Costa, Paulo P ^b,c   Torres, Paulo A ^a,b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c NATIONAL INSTITUTE OF HEALTH   (Portugal)

Author keywords

Amyloid; Familial amyloidotic polyneuropathy; Glaucoma; Vitrectomy; Vitreous

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GLAUCOMA; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; LIVER TRANSPLANTATION; MALE; PORTUGAL; PRIORITY JOURNAL; RETINA DETACHMENT; VITRECTOMY; VITREOUS OPACITY;

ADULT; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; GLAUCOMA; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUTATION, MISSENSE; PREALBUMIN; VITRECTOMY; VITREOUS BODY;

EID: 84865218034     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2012.710669     Document Type: Article

References (65)

1. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-427.
2. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288-294. (Pubitemid 23252087)
3. Reilly MM, Adams D, Booth DR, Davis MB, Said G, Laubriat-Bianchin M, Pepys MB, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118 (Pt 4):849-856.
4. Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58:1001-1007. (Pubitemid 34298536)
5. Munar-Ques M, Costa PP, Saraiva MJ, Viader-Farre C, Munar-Bernat C. [Familial type I (Portuguese form) amyloidotic polyneuropathy in Majorca. Study using the TTR (Met30) genetic marker]. Med Clin (Barc) 1988;91:441-444.
6. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512-521. (Pubitemid 26002118)
7. Benson MD, Cohen AS. Generalized amyloid in a family of Swedish origin. A study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med 1977;86:419-424. (Pubitemid 8078950)
8. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057-1062. (Pubitemid 41043725)
9. Saraiva MJ, Costa PP, Birken S, Goodman DS. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians 1983;96:261-270.
10. Monaco HL. The transthyretin-retinol-binding protein complex. Biochim Biophys Acta 2000;1482:65-72.
11. Dwork AJ, Cavallaro T, Martone RL, Goodman DS, Schon EA, Herbert J. Distribution of transthyretin in the rat eye. Invest Ophthalmol Vis Sci 1990;31:489-496. (Pubitemid 20117064)
12. Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, Inomata Y, et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res 2005;81:306-312. (Pubitemid 41208165)
13. Connors LH, Richardson AM, Theberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54-69.
14. Okamoto S, Wixner J, Obayashi K, Ando Y, Ericzon BG, Friman S, Uchino M, Suhr OB. Liver transplantation for familial amyloidotic polyneuropathy: impact on Swedish patients' survival. Liver Transpl 2009;15:1229-1235.
15. Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, Gjertsen H, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant 2007;7:2597-2604. (Pubitemid 47561612)
16. Suhr OB, Friman S, Ericzon BG. Early liver transplantation improves familial amyloidotic polyneuropathy patients' survival. Amyloid 2005;12:233-238. (Pubitemid 43096382)
17. Jonsen E, Suhr OB, Tashima K, Athlin E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid 2001;8:52-57. (Pubitemid 32210180)
18. Sandgren O, Kjellgren D, Suhr OB. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol 2008;86:520-524.
19. Munar-Ques M, Salva-Ladaria L, Mulet-Perera P, Sole M, Lopez- Andreu FR, Saraiva MJ. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid 2000;7:266-269.
20. Haraoka K, Ando Y, Ando E, Sun X, Nakamura M, Terazaki H, Misumi S, et al. Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid 2002;9:247-251. (Pubitemid 36132520)
21. Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch Ophthalmol 2010;128:206-210.
22. Sandgren O, Stenkula S, Dedorsson I. Vitreous surgery in patients with primary neuropathic amyloidosis. Acta Ophthalmol (Copenh) 1985;63:383-388. (Pubitemid 15227393)
23. Doft BH, Machemer R, Skinner M, Buettner H, Clarkson J, Crock J, McLeod D, et al. Pars plana vitrectomy for vitreous amyloidosis. Ophthalmology 1987;94:607-611. (Pubitemid 17085034)
24. Monteiro JG, Martins AF, Figueira A, Saraiva MJ, Costa PP. Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities. Eye (Lond) 1991;5 (Pt 1):99-105.
25. Koga T, Ando E, Hirata A, Fukushima M, Kimura A, Ando Y, Negi A, Tanihara H. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am J Ophthalmol 2003;135:188-193. (Pubitemid 36151796)
26. Beirao NM, Matos E, Beirao I, Costa PP, Torres P. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M. Retina (Philadelphia, Pa) 2011;31:1373-1377.
27. Frau E, Lautier-Frau M, Saindelle-Ribeaudeau F, Adams D, Bousquet A, Labetoulle M, Offret H. [Familial amyloid polyneuropathy type I complicated by chronic glaucoma: 3 cases]. J Fr Ophthalmol 2000;23: 217-220. (Pubitemid 30212338)
28. Vella FS, Simone B, Giannelli G, Sisto D, Sborgia C, Antonaci S. Glaucoma in primary amyloidosis: a fortuitous or causative association? Am J Med 2002;113:252-254. (Pubitemid 35245641)
29. Kawaji T, Ando Y, Hara R, Tanihara H. Novel therapy for transthyretinrelated ocular amyloidosis: a pilot study of retinal laser photocoagulation. Ophthalmology 2010;117:552-555.
30. Silva-Araujo AC, Tavares MA, Cotta JS, Castro-Correia JF. Aqueous outflow system in familial amyloidotic polyneuropathy, Portuguese type. Graefes Arch Clin Exp Ophthalmol 1993;231:131-135. (Pubitemid 23088017)
31. Miyahara T, Ohta K, Yamamoto Y, Ueno A, Murata T. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy. J Glaucoma 2007;16:169-170. (Pubitemid 46114793)
32. Kawaji T, Ando Y, Hara R, Tanihara H. Novel therapy for transthyretinrelated ocular amyloidosis: a pilot study of retinal laser photocoagulation. Ophthalmology 2010;117:552-555.
33. Grus FH, Joachim SC, Sandmann S, Thiel U, Bruns K, Lackner KJ, Pfeiffer N. Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis 2008;14:1437-1445.
34. Kimura A, Ando E, Fukushima M, Koga T, Hirata A, Arimura K, Ando Y, et al. Secondary glaucoma in patients with familial amyloidotic polyneuropathy. Arch Ophthalmol 2003;121:351-356. (Pubitemid 36298117)
35. Yu AL, Brummeisl W, Schaumberger M, Kampik A, Welge-Lussen U. Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension-a 5-year follow-up. Graefes Arch Clin Exp Ophthalmol 2010;248:1407-1414.
36. Chang S. LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol 2006;141:1033-1043.
37. Tezel G. The immune response in glaucoma: a perspective on the roles of oxidative stress. Exp Eye Res 2011;93:178-186.
38. Oshida E, Matsumoto Y, Arai K. Free radicals in the aqueous humor of patients with glaucoma. Clin Ophthalmol 2010;4:653-660.
39. Tezel G, Yang X, Luo C, Kain AD, Powell DW, Kuehn MH, Kaplan HJ. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci 2010;51:5071-5082.
40. Ghanem AA, Arafa LF, El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr Eye Res 2010;35:295-301.
41. Yuki K, Murat D, Kimura I, Ohtake Y, Tsubota K. Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 2010;248:243-248.
42. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004;137:62-69. (Pubitemid 38045188)
43. Holekamp NM. The vitreous gel: more than meets the eye. Am J Ophthalmol 2010;149:32-36.
44. Macedo B, Magalhaes J, Batista AR, Saraiva MJ. Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacol Res 2010;62:514-522.
45. Macedo B, Batista AR, do Amaral JB, Saraiva MJ. Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy. Mol Med 2007;13:584-591. (Pubitemid 350228719)
46. Teixeira PF, Cerca F, Santos SD, Saraiva MJ. Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy. J Biol Chem 2006;281:21998-22003. (Pubitemid 44181903)
47. Saraiva MJ. Cellular consequences of transthyretin deposition. Amyloid 2003;10 Suppl 1:13-16. (Pubitemid 37372561)
48. Fiszman ML, Di Egidio M, Ricart KC, Repetto MG, Borodinsky LN, Llesuy SF, Saizar RD, et al. Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1. Arch Neurol 2003;60:593-597. (Pubitemid 36427974)
49. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 2000;19:323-344. (Pubitemid 30122726)
50. Quintas A, Saraiva MJ, Brito RM. The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis. J Biol Chem 1999;274:32943-32949. (Pubitemid 129535333)
51. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-596. (Pubitemid 36951371)
52. Sousa MM, Cardoso I, Fernandes R, Guimaraes A, Saraiva MJ. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 2001;159:1993-2000. (Pubitemid 33104254)
53. Zenkel M, Lewczuk P, Junemann A, Kruse FE, Naumann GO, Schlotzer- Schrehardt U. Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol 2010;176:2868-2879.
54. Brown CM, Dutsch M, Michelson G, Neundorfer B, Hilz MJ. Impaired cardiovascular responses to baroreflex stimulation in open-angle and normal-pressure glaucoma. Clin Sci 2002;102:623-630. (Pubitemid 34620892)
55. Clark CV, Mapstone R. Systemic autonomic neuropathy in open-angle glaucoma. Doc Ophthalmol 1986;64:179-185. (Pubitemid 17079770)
56. Kumar R, Ahuja VM. A study of changes in the status of autonomic nervous system in primary open angle glaucoma cases. Indian J Med Sci 1999;53:529-534.
57. Riccadonna M, Covi G, Pancera P, Presciuttini B, Babighian S, Perfetti S, Bonomi L, Lechi A. Autonomic system activity and 24-hour blood pressure variations in subjects with normal- and high-tension glaucoma. J Glaucoma 2003;12:156-163. (Pubitemid 36427704)
58. Reiss GR, Lee DA, Topper JE, Brubaker RF. Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci 1984;25:776-778. (Pubitemid 14082992)
59. Plante-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2007;69:693-698. (Pubitemid 47256013)
60. Coutinho CA, Conceicao I, Almeida A, Cantinho G, Sargento L, Vagueiro MC. Early detection of sympathetic myocardial denervation in patients with familial amyloid polyneuropathy type I. Rev Port Cardiol 2004;23:201-211. (Pubitemid 38523871)
61. Davies DR, Smith SE. Pupil abnormality in amyloidosis with autonomic neuropathy. J Neurol Neurosurg Psychiatr 1999;67:819-822.
62. Carvalho MJ, van Den Meiracker AH, Boomsma F, Lima M, Freitas J, Veld AJ, Falcao De Freitas A. Diurnal blood pressure variation in progressive autonomic failure. Hypertension 2000;35:892-897. (Pubitemid 30303946)
63. Pandit A, Gangurde S, Gupta SB. Autonomic failure in primary amyloidosis. J Assoc Physicians India 2008;56:995-996.
64. Ando Y, Suhr OB. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 1998;5:288-300. (Pubitemid 128690769)
65. Gherghel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 2004;49:491-508. (Pubitemid 39504764)